Caballero Jorge A.
Known title: DirectorCIK: 0001899928
Caballero Jorge A.'s purchase track record
Caballero Jorge A. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/6/2024 | AMN | $114K | -8.2% | -8.7% | +8.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| AMN | ▲ Buy | Option Exercise | 8,325 | $0 | 5/1/2026 | View on chart |
| AMN | ▲ Buy | Option Exercise | 3,019 | $0 | 4/19/2025 | View on chart |
| AMN | ▲ Buy | Option Exercise | 1,681 | $0 | 4/19/2024 | View on chart |
| AMN | ▲ Buy | Open Market | 2,000 | $114K | 3/6/2024 | View on chart |
| AMN | ▲ Buy | Option Exercise | 437 | $0 | 4/21/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
AMN Healthcare Maintains Outperform Rating, Target Raised to $43
Analyst BMO Capital kept an Outperform rating on AMN Healthcare and increased its price target to $43. The company announced a third‑quarter 2026 earnings conference call scheduled for November 5. The stock trades near its $33.96 support level and carries a trailing P/E of 13.4, while analysts’ average target is $36.14.
AMN Healthcare Maintains Outperform Rating, Target Raised to $43. Analyst BMO Capital kept an Outperform rating on AMN Healthcare and increased its price target to $43. The company announced a third‑quarter 2026 earnings conference call scheduled for November 5. The stock trades near its $33.96 support level and carries a trailing P/E of 13.4, while analysts’ average target is $36.14.